The Valley Desk

ArticleThe American journal of gastroenterologyPublished

Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
The American journal of gastroenterology
Published
Subject terms
Humans; Colitis, Ulcerative; Inflammatory Bowel Diseases; Crohn Disease; Biological Products; Biological Therapy; Drug Therapy, Combination; Remission Induction; Adult; Aged; Middle Aged; Female
PubMed ID
40243385
PubMed Central ID
PMC12662134
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal